Budget impact analysis of PCSK9 inhibitors costs from a community payers’ perspective in Apulia, Italy

INTRODUCTION: Despite established clinical efficacy of PCSK9 inhibitors (PCSK9i) in reducing cardiovascular events, their cost still represents a big matter of debate. We therefore sought to estimate possible impact of PCSK9i therapy from a community taxpayers’ perspective with a budget impact analy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Heart
Egile Nagusiak: Brunetti, Natale Daniele, De Gennaro, Luisa, Tricarico, Lucia, Caldarola, Pasquale
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2019
Gaiak:
Health Care Delivery, Economics and Global Health Care
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6667935/
https://ncbi.nlm.nih.gov/pubmed/31413843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2019-001018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak